Clinical Trials Directory

Trials / Conditions / Macular Degeneration, Age-Related

Macular Degeneration, Age-Related

15 registered clinical trials studyying Macular Degeneration, Age-Related1 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingEfficacy of Faricimab in Patients With Subretinal Hyper-reflective Material
NCT07403825
Biobizkaia Health Research InstitutePhase 4
CompletedCRYSTALSIGHT: ''Cohort 1.5" Clinical Investigation Study With OCCUTRACK and Tan Tock Seng Eye Clinic to Furthe
NCT07255885
Tan Tock Seng Hospital
Active Not RecruitingA Study to Test Whether BI 771716 Helps People With an Advanced Form of Age-related Macular Degeneration (AMD)
NCT06722157
Boehringer IngelheimPhase 2
CompletedCOmparison of Clarus and Optos Ultrawide Field Imaging Systems for Geographic Atrophy
NCT05961332
University of Wisconsin, MadisonN/A
CompletedEffect of Minimizing Light Exposure Intensity on Macular Function After Cataract Surgery in Patients With Earl
NCT05988827
ElsanN/A
CompletedVISUPRIME® Eye Drops
NCT05677685
VISUfarma SpAN/A
Active Not RecruitingEvaluating Metabolic Changes Induced by PhotoBioModulation Through Spectrally Resolved Autofluorescence in Dry
NCT06582511
Francesco Bandello
CompletedClinical Evaluation of VeriSee AMD in Screening for Age-Related Macular Degeneration
NCT05593913
Acer Medical Inc.
TerminatedA Study Assessing the Long-Term Safety and Tolerability of Galegenimab (FHTR2163) in Participants With Geograp
NCT04607148
Genentech, Inc.Phase 2
TerminatedA Study Assessing the Safety, Tolerability, and Efficacy of Galegenimab (FHTR2163) in Participants With Geogra
NCT03972709
Genentech, Inc.Phase 2
CompletedComparison of Cytokine Profiles in Aqueous Humor of Patients With Age Related Macular Degeneration (AMD)
NCT03418220
Hospices Civils de LyonN/A
CompletedStudy to Evaluate Faricimab (RO6867461; RG7716) for Extended Durability in the Treatment of Neovascular Age Re
NCT03038880
Hoffmann-La RochePhase 2
TerminatedOxidative Stress In Stargardt Disease, Age Related Macular Degeneration and Diabetic Retinopathy
NCT02875704
Johns Hopkins University
CompletedMetformin for the Minimization of Geographic Atrophy Progression in Patients With AMD
NCT02684578
University of California, San FranciscoPhase 2
TerminatedVisual Enhancement Device in Low Vision Patients
NCT03794752
University of Texas Southwestern Medical CenterN/A